Evaluation of the efficacy of ultrasound-guided maxillary and mandibular nerve pulsed radiofrequency treatment for trigeminal neuralgia and factors associated with successful response: a retrospective study
Acta Neurologica Belgica · 2025
DOI: 10.1007/s13760-024-02638-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neurologica Belgica, 2025. Verfasst von Ezgi Can und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ankara Etlik City Hospital, Algology Department, Ankara, Turkey. ezgiacarcan89@gmail.com. Hauptthemen laut MEDLINE: Trigeminal Neuralgia, Pulsed Radiofrequency Treatment, Ultrasonography, Interventional, Mandibular Nerve. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: This study aimed to investigate the treatment efficacy and clinical and demographic characteristics affecting treatment success in patients who underwent ultrasound (US)-guided pulsed radiofrequency (PRF) to the maxillary and/or mandibular nerves for trigeminal neuralgia. METHODS: The data of patients with trigeminal neuralgia who underwent US-guided maxillary and/or mandibular nerve PRF between September 2022 and December 2023 were reviewed and the study was retrospectively designed. Good analgesia was defined as ≥ 50% reduction in pain score at 3 months after the procedure, and the demographic and clinical characteristics of the patients were assessed. RESULTS: Among the 72 included patients, 39 (54.2%) and 33 (45.8%) were classified as responders and non-responders, respectively. The age, pre- and post-procedural Numerical Rating Scale (NRS) scores, pain duration, and presence of constant pain were significantly lower in the responders. Logistic regression analysis revealed that older age (OR = 0.899, p < 0.001), high pre-procedural NRS scores (OR = 0.177, p = 0.009) and non-idiopathic (secondary or classic) etiology (OR = 0.062, p = 0.048) were significantly associated with an unsuccessful response to maxillary/mandibular PRF treatment. CONCLUSION: This study is the first clinical trial to evaluate the efficacy of PRF therapy of the maxillary and mandibular nerves in the treatment of trigeminal neuralgia and demonstrated a significant reduction in pain scores at 3 months. Older age, high pre-procedural NRS scores, and non-idiopathic (secondary or classical) etiology are independent predictors of poor response to ultrasound-guided maxillary/mandibular nerve pulse radiofrequency treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ankara Etlik City Hospital, Algology Department, Ankara, Turkey. ezgiacarcan89@gmail.com.
- Ankara Etlik City Hospital, Algology Department, Ankara, Turkey.
Zitieren
APA
Can, E., Perdecioğlu, G. R. G., Yıldız, G., Yürük, D., & Akkaya, Ö. T. (2025). Evaluation of the efficacy of ultrasound-guided maxillary and mandibular nerve pulsed radiofrequency treatment for trigeminal neuralgia and factors associated with successful response: a retrospective study. Acta Neurologica Belgica. https://doi.org/10.1007/s13760-024-02638-2
Vancouver
Can E, Perdecioğlu GRG, Yıldız G, Yürük D, Akkaya ÖT. Evaluation of the efficacy of ultrasound-guided maxillary and mandibular nerve pulsed radiofrequency treatment for trigeminal neuralgia and factors associated with successful response: a retrospective study. Acta Neurologica Belgica. 2025. doi:10.1007/s13760-024-02638-2
BibTeX
@article{Can2025,
author = {Can, Ezgi and Perdecioğlu, Gevher Rabia Genç and Yıldız, Gökhan and Yürük, Damla and Akkaya, Ömer Taylan},
title = {Evaluation of the efficacy of ultrasound-guided maxillary and mandibular nerve pulsed radiofrequency treatment for trigeminal neuralgia and factors associated with successful response: a retrospective study},
journal = {Acta Neurologica Belgica},
year = {2025},
doi = {10.1007/s13760-024-02638-2}
}
EUVIMED